The Rho Guanosine 5′-Triphosphatase, Cell Division Cycle 42, Is Required for Insulin-Induced Actin Remodeling and Glucagon-Like Peptide-1 Secretion in the Intestinal Endocrine L Cell

被引:33
|
作者
Lim, Gareth E. [1 ]
Xu, Molie [1 ]
Sun, Jane [2 ]
Jin, Tianru [1 ,2 ,3 ,4 ]
Brubaker, Patricia L. [1 ,3 ]
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada
[4] Univ Hlth Network, Div Cellular & Mol Biol, Toronto, ON M5G 1L7, Canada
关键词
CROSS-CASCADE ACTIVATION; BETA-CELL; CORTICAL ACTIN; REGULATED EXOCYTOSIS; NEUROENDOCRINE CELLS; ARP2/3; COMPLEX; PROTEIN-KINASE; CDC42; GLUCOSE; CYTOSKELETON;
D O I
10.1210/en.2009-0508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rho GTPases, such as cell division cycle 42 (Cdc42) and ras-related C3 botulinum toxin substrate 1 (Rac1), have been identified as regulators of F-actin dynamics and hormone release from endocrine cells; however, their role in secretion of the incretin hormone, glucagon-like peptide-1 (GLP-1), from the enteroendocrine L cell is unknown. Insulin induced a 1.4-fold increase in L cell GLP-1 release; however, secretion was potentiated to 2.1-fold in the presence of the F-actin depolymerizing agent, latrunculin B, suggesting that F-actin functions as a permissive barrier. In murine GLUTag L cells, insulin stimulated F-actin depolymerization and Cdc42 activation simultaneously, and these events occurred prior to detectable increases in insulin-induced GLP-1 release. After insulin treatment, Cdc42-dependent p21-activated kinase-1 (PAK1) activation was also detected, and transfection of small-interfering RNA against Cdc42 or of dominant-negative Cdc42(T17N) impaired insulin-stimulated PAK1 activation, actin remodeling, and GLP-1 secretion. Overexpression of kinase-dead PAK1(K299R) or PAK1 small interfering RNA similarly attenuated insulin-induced GLP-1 secretion. Knockdown or inhibition of Cdc42 and PAK1 activities also prevented activation of MAPK/ERK (MEK)-1/2-ERK1/2 by insulin, which was previously identified as a critical pathway for insulin-regulated GLP-1 release. Taken together, these data identify a novel signaling pathway in the endocrine L cell, whereby Cdc42 regulates actin remodeling, activation of the cannonical 1/2-ERK1/2 pathway and PAK1, and GLP-1 secretion in response to insulin. (Endocrinology 150: 5249-5261, 2009)
引用
收藏
页码:5249 / 5261
页数:13
相关论文
共 9 条
  • [1] Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell
    Mulherin, Andrew J.
    Oh, Amy H.
    Kim, Helena
    Grieco, Anthony
    Lauffer, Lina M.
    Brubaker, Patricia L.
    ENDOCRINOLOGY, 2011, 152 (12) : 4610 - 4619
  • [2] Rb and p107 are required for alpha cell survival, beta cell cycle control and glucagon-like peptide-1 action
    Cai, Erica P.
    Luk, Cynthia T.
    Wu, Xiaohong
    Schroer, Stephanie A.
    Shi, Sally Yu
    Sivasubramaniyam, Tharini
    Brunt, Jara J.
    Zacksenhaus, Eldad
    Woo, Minna
    DIABETOLOGIA, 2014, 57 (12) : 2555 - 2565
  • [3] Rb and p107 are required for alpha cell survival, beta cell cycle control and glucagon-like peptide-1 action
    Erica P. Cai
    Cynthia T. Luk
    Xiaohong Wu
    Stephanie A. Schroer
    Sally Yu Shi
    Tharini Sivasubramaniyam
    Jara J. Brunt
    Eldad Zacksenhaus
    Minna Woo
    Diabetologia, 2014, 57 : 2555 - 2565
  • [4] Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment
    Rasouli, Mina
    Ahmad, Zalinah
    Omar, Abdul Rahman
    Allaudin, Zeenathul N.
    BMC BIOTECHNOLOGY, 2011, 11
  • [5] Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell
    Li, Pengzhou
    Zhu, Liyong
    Yang, Xiangwu
    Li, Weizheng
    Sun, Xulong
    Yi, Bo
    Zhu, Shaihong
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 12839 - 12846
  • [6] Role of fatty acid transport protein 4 in oleic acid-induced glucagon-like peptide-1 secretion from murine intestinal L cells
    Poreba, M. A.
    Dong, C. X.
    Li, S. K.
    Stahl, A.
    Miner, J. H.
    Brubaker, P. L.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2012, 303 (07): : E899 - E907
  • [7] Increased Glucose-induced Secretion of Glucagon-like Peptide-1 in Mice Lacking the Carcinoembryonic Antigenrelated Cell Adhesion Molecule 2 (CEACAM2)
    Ghanem, Simona S.
    Heinrich, Garrett
    Lester, Sumona G.
    Pfeiffer, Verena
    Bhattacharya, Sumit
    Patel, Payal R.
    DeAngelis, Anthony M.
    Dai, Tong
    Ramakrishnan, Sadeesh K.
    Smiley, Zachary N.
    Jung, Dae Y.
    Lee, Yongjin
    Kitamura, Tadahiro
    Ergun, Suleyman
    Kulkarni, Rohit N.
    Kim, Jason K.
    Giovannucci, David R.
    Najjar, Sonia M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (02) : 980 - 988
  • [8] Cav1.2 and Cav1.3 Are Differentially Coupled to Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion in the Pancreatic β-Cell Line INS-1
    Jacobo, Sarah Melissa P.
    Guerra, Marcy L.
    Hockerman, Gregory H.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (02) : 724 - 732
  • [9] RETRACTED: Farnesoid X Receptor (FXR) Interacts with Camp Response Element Binding Protein (CREB) to Modulate Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Secretion by Intestinal L Cell (Retracted Article)
    Li, Pengzhou
    Zhu, Liyong
    Yang, Xiangwu
    Li, Weizheng
    Sun, Xulong
    Yi, Bo
    Zhu, Shaihong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (04) : 1442 - 1452